中文名稱:兔抗CCDC134多克隆抗體
英文名稱: Anti-CCDC134 rabbit polyclonal antibody
別 名: coiled-coil domain containing 134
儲 存: 冷凍(-20℃)
宿 主: Rabbit
抗 原: CCDC134
反應種屬: Human, Mouse, Rat
標 記 物: Unconjugate
克隆類型: rabbit polyclonal
技術規格
Background: |
In extracellular secreted form, promotes proliferation and activation of CD8+ T cells, suggesting a cytokine-like function (PubMed:25125657). Enhances cytotoxic anti-tumor activity of CD8+ T cells (PubMed:25125657). May inhibit ERK and JNK signaling activity (PubMed:18087676, PubMed:23070808). May suppress cell migration and invasion activity, via its effects on ERK and JNK signaling (PubMed:23070808). In the nucleus, enhances stability of the PCAF histone acetyltransferase (HAT) complex member TADA2A and thus promotes PCAF-mediated H3K14 and H4K8 HAT activity. May inhibit TADA2A-mediated TP53/p53 'Lys-321' acetylation, leading to reduced TP53 stability and transcriptional activity. May also promote TADA2A-mediated XRCC6 acetylation thus facilitating cell apoptosis in response to DNA damage. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
CCDC134 |
Immunogen: |
Fusion protein of human CCDC134 |
Full name: |
coiled-coil domain containing 134 |
SwissProt: |
Q9H6E4 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human liver cancer |
IHC Recommend dilution: |
50-200 |
WB Predicted band size: |
27 kDa |
WB Positive control: |
Human fetal liver tissue, 293T cell lysates |
WB Recommended dilution: |
1000-5000 |